Market revenue in 2023 | USD 17.5 million |
Market revenue in 2030 | USD 25.2 million |
Growth rate | 5.3% (CAGR from 2023 to 2030) |
Largest segment | Male infertility treatment |
Fastest growing segment | Male Infertility Diagnosis |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Male Infertility Diagnosis, Male Infertility Treatment |
Key market players worldwide | Aytu BioPharma Inc, Bayer AG, Merck KGaA, Zydus Lifesciences, Andrology Solutions, Halotech DNA, SCSA Diagnostics, Intas Pharmaceuticals |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to male infertility market will help companies and investors design strategic landscapes.
Male infertility treatment was the largest segment with a revenue share of 92% in 2023. Horizon Databook has segmented the Sweden male infertility market based on male infertility diagnosis, male infertility treatment covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Sweden male infertility market , including forecasts for subscribers. This country databook contains high-level insights into Sweden male infertility market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account